The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 1b/2 trial of SHR-1701 in combination with gemcitabine and nab-paclitaxel in patients with untreated locally advanced or metastatic pancreatic cancer.
 
Jun Zhou
No Relationships to Disclose
 
Xianjun Yu
No Relationships to Disclose
 
Zhihua Li
No Relationships to Disclose
 
Yuhong Zhou
No Relationships to Disclose
 
Jialin Li
No Relationships to Disclose
 
Ran Xue
No Relationships to Disclose
 
Ye Xia
Employment - Jiangsu Hengrui Medicine
 
Hongxia Han
Employment - Jiangsu Hengrui Medicine
 
Yiwen Wu
Employment - Jiangsu Hengrui Medicine
 
Lin Shen
Consulting or Advisory Role - AstraZeneca; Bristol-Myers Squib; Daiichi Sankyo; Harbour BioMed; Merck; Mingji biopharmaceutical; MSD; Roche
Speakers' Bureau - Hutchison Whampoa; MSD
Research Funding - Baiji Shenzhou (Beijing) Biotechnology (Inst); Beijing Xiantong Biomedical Technology (Inst); Nanjing Yaojieankang Biotechnology (Inst); QiLu Pharmaceutical (Inst); Zaiding Pharmaceutical (Inst)